- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Edgerton leaves Kodak PACS business
Ron Edgerton has stepped down from his position as general managerof Kodak's Medical Imaging Systems group, the Dallas businessunit that handles the company's efforts in PACS and digital imaging.Edgerton has been replaced by Richard Cimino, who
Ron Edgerton has stepped down from his position as general managerof Kodak's Medical Imaging Systems group, the Dallas businessunit that handles the company's efforts in PACS and digital imaging.Edgerton has been replaced by Richard Cimino, who previously wasgeneral manager of the U.S. northeast region for Kodak HealthImaging, the Dallas unit's parent in Rochester, NY.
Edgerton had replaced Catherine Burzik as head of the Dallasunit when he assumed the position last November. Edgerton previouslywas CFO of the Dallas business, and left the company for a jobin the financial services industry.
Edgerton is the second high-ranking executive to leave Kodak'sPACS effort in the past several months. Shridar Seshadri, responsiblefor strategic planning and archiving, left Kodak in August. Seshadri'sresponsibilities in the archiving sector have been assumed byLori Martin.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
